ABBV — Abbvie Income Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeLarge CapHigh Flyer

Annual income statement for Abbvie, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	56,197	58,054	54,318	56,334	61,160
Cost of Revenue
Gross Profit	38,883	41,527	36,092	39,430	43,803
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	38,273	39,937	41,561	47,197	46,085
Operating Profit	17,924	18,117	12,757	9,137	15,075
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	12,989	13,477	6,250	3,716	6,597
Provision for Income Taxes
Net Income After Taxes	11,549	11,845	4,873	4,286	4,233
Minority Interest
Net Income Before Extraordinary Items
Net Income	11,542	11,836	4,863	4,278	4,226
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	11,468	11,782	4,820	4,238	4,186
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	7.32	7.78	4.54	5.97	5.6
Dividends per Share